Improved eGFR and reduced renal fibrosis and inflammation by downregulating inflammatory genes like C3, CCL2, and TNFα and modulating angiogenesis, fibrosis, inflammation, and proliferation pathways. The gene discussed is C3; the disease is renal fibrosis.